Tectonic Therapeutic Inc. (TECX) Balance Sheet

NASDAQ: TECXAssets, liabilities, debt and equity over 10 years.

TECX balance sheet, 2025

December 31, 2025 · U.S. dollars

$261.0M assets = $9.7M liabilities + $251.3M equity

What it owns$261.0MCash & ST investments: $253.8M (97.2%)Cash & ST investments$253.8M · 97%Other current: $3.6M (1.4%)PP&E: $2.6M (1.0%)Other non-current: $1.1M (0.4%)=How it is financed$261.0MCurrent liabilities: $9.7M (3.7%)Other LT liabilities: $43,000 (0.0%)Shareholders’ equity: $251.3M (96.3%)Shareholders’ equity$251.3M · 96%

Both columns are drawn to the same scale: what TECX owns equals what it owes plus shareholders’ equity. Hover a block for its value.

TECX financial health

Debt / equity0.01
Low leverage · $0.01 of debt for each $1 of equity
Equity / assets96.3%
Equity-funded · of assets funded by shareholders
Cash / debt19,890.1%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

TECX balance sheet trends, 2016–2025

Tectonic Therapeutic Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$5.4M2016$261.0M2025+53.9%/yr
Total liabilities$979,0002016$9.7M2025+29.0%/yr
Shareholders’ equity$4.4M2016$251.3M2025+56.7%/yr
Cash & short-term investments$5.4M2016$253.8M2025+53.5%/yr
Total debt$1.1M2021$1.3M2025+4.9%/yr
Net cash (debt)$27.0M2021$252.5M2025+$225.5M
Working capital$4.5M2016$247.7M2025+$243.2M
Book value per share$9.532024$13.722025+43.9%/yr
Debt / equity0.0220240.012025−0.02
Shares outstanding14.8M202418.3M2025+24.1%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

TECX assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

TECX liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

TECX debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

TECX balance sheet

Tectonic Therapeutic Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$253.8M$141.2M$28.8M$36.0M$28.1M$259.7M$187.0M$126.3M$6.0M$5.4M
Cash & equivalents$253.8M$141.2M$28.8M$36.0M$28.1M$259.7M$187.0M$126.3M$6.0M$5.4M
Receivables$0$0$0$269,000$2.7M$2.6M$2.1M$1.5M$0$0
Inventory$0$0$0$0$0$0$0$0$0$0
Other current assets$3.6M$5.6M$2.1M$807,000$0$5.0M$6.5M$2.2M$345,000$19,000
Total current assets$257.4M$146.9M$30.9M$37.0M$28.6M$267.2M$195.7M$130.0M$6.3M$5.4M
Property, plant & equipment (net)$2.6M$5.3M$7.2M$9.6M$3.7M$3.1M$3.7M$2.6M$349,000$0
Goodwill & intangible assets$0$0$0$0$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0$0$0$0$0
Other non-current assets$1.1M$743,000$1.3M$613,000$599,000$928,000$1.1M$825,000$365,000$24,000
Total assets$261.0M$152.9M$39.4M$47.2M$32.9M$271.2M$200.5M$133.5M$7.0M$5.4M
Liabilities
Accounts payable$1.1M$976,000$409,000$574,000$1.8M$2.7M$3.9M$2.8M$527,000$340,000
Short-term debt$1.2M$2.8M$1.8M$1.4M$355,000—————
Deferred revenue——−$878,000—−$355,000—————
Total current liabilities$9.7M$11.6M$40.9M$7.8M$4.1M$16.6M$14.0M$10.6M$2.6M$891,000
Long-term debt$0$0$0$0$0$0$0$0$0$0
Lease obligations$1.3M$3.3M$4.3M$5.8M$1.1M—————
Other long-term liabilities$43,000$519,000$83.1M$85.0M$43.7M$276,000$484,000$689,000$1.0M$87,999
Total liabilities$9.7M$12.1M$124.0M$92.9M$47.8M$16.9M$14.5M$11.3M$3.7M$979,000
Shareholders' equity
Common stock & paid-in capital$2,000$2,000$4,000$4,000$4,000$4,000$3,000$2,000$1,000$1,000
Retained earnings (deficit)−$222.7M−$148.6M−$90.6M−$47.8M−$15.6M−$264.4M−$144.7M−$71.7M−$23.5M−$4.8M
Accumulated other comprehensive income−$96,000$9,000−$11,000$0−$42.6M———−$1,000−$1,000
Total shareholders' equity$251.3M$140.8M−$84.6M−$45.7M−$15.0M$254.3M$186.0M$122.2M$3.4M$4.4M
Key figures
Total debt$1.3M$3.3M$4.3M$5.8M$1.1M—————
Net cash (debt)$252.5M$137.9M$24.4M$30.2M$27.0M—————
Working capital$247.7M$135.2M−$10.0M$29.2M$24.5M$250.6M$181.7M$119.4M$3.7M$4.5M
Tangible book value$251.3M$140.8M−$84.6M−$45.7M−$15.0M$254.3M$186.0M$122.2M$3.4M$4.4M
Book value per share$13.72$9.53————————
Shares outstanding18.3M14.8M————————
Current ratio26.6312.650.764.736.9516.0913.9612.262.406.03
Quick ratio26.2612.170.704.627.4715.7813.5012.052.276.01
Debt / equity0.010.02————————
Equity / assets96.3%92.1%−214.8%−96.7%−45.5%93.8%92.8%91.5%47.9%81.9%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 26, 2026); data from EODHD.

TECX financial position

At the end of fiscal 2025 (December 31, 2025), Tectonic Therapeutic had total assets of $261.0 million (up 70.7% from a year earlier), total liabilities of $9.7 million and shareholders' equity of $251.3 million. It held $253.8 million in cash and short-term investments against $1.3 million of debt, a net cash position of $252.5 million. Its current ratio was 26.63. In the latest quarter (ended June 30, 2026) total assets were $237.0 million and equity $223.8 million.

Related: TECX income statement, TECX cash flow statement, TECX key metrics. See the TECX stock overview for the latest quote and news.

TECX balance sheet FAQ

What are Tectonic Therapeutic's total assets?

Tectonic Therapeutic reported total assets of $261.0 million at the end of fiscal 2025 (December 31, 2025), compared with $152.9 million a year earlier.

How much debt does Tectonic Therapeutic have?

Tectonic Therapeutic had $1.3 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.01.

How much cash does Tectonic Therapeutic have?

Tectonic Therapeutic held $253.8 million in cash and short-term investments at the end of fiscal 2025; with $1.3 million of debt that is net cash of $252.5 million.

What is Tectonic Therapeutic's book value?

Tectonic Therapeutic's shareholders' equity (book value) was $251.3 million at the end of fiscal 2025, or $13.72 per share.

What is Tectonic Therapeutic's current ratio?

Tectonic Therapeutic had current assets of $257.4 million and current liabilities of $9.7 million, a current ratio of 26.63 (it can cover its short-term obligations).

Biotechnology: balance sheet